<DOC>
	<DOCNO>NCT01490190</DOCNO>
	<brief_summary>This study collect information cycle control , acceptability tolerability vaginal contraceptive ring ( NuvaRing ) use normal daily practice Indian woman .</brief_summary>
	<brief_title>Study Use Contraceptive Vaginal Ring ( NuvaRing ) Normal Daily Practice Indian Women ( P07733 )</brief_title>
	<detailed_description />
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Desogestrel</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Etonogestrel</mesh_term>
	<criteria>Women risk pregnancy seek contraception Exclusion criterion base approve prescribe information India : Presence history venous thrombosis , without pulmonary embolism . Presence history arterial thrombosis ( e.g . cerebrovascular accident , myocardial infarction ) prodromi thrombosis ( e.g . angina pectoris transient ischemic attack ) . Known predisposition venous arterial thrombosis , without hereditary involvement Activated Protein C ( APC ) resistance , antithrombinIII deficiency , protein C deficiency , protein S deficiency , hyperhomocysteinemia antiphospholipid antibody ( anticardiolipin antibody , lupus anticoagulant ) . History migraine focal neurological symptom . Diabetes mellitus vascular involvement . The presence severe multiple risk factor ( ) venous arterial thrombosis ( discretion doctor ) Pancreatitis history thereof associate severe hypertriglyceridemia . Presence history severe hepatic disease long liver function value return normal . Presence history liver tumor ( benign malignant ) . Known suspected malignant condition genital organ breast , sex steroidinfluenced . Undiagnosed vaginal bleeding . Known suspected pregnancy . Hypersensitivity active substance excipients NuvaRing . Women breast feed</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>